Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice
Source: SeekingAlpha
2026-01-30 16:29:40 ET
More on Galmed
- Seeking Alpha’s Quant Rating on Galmed
- Historical earnings data for Galmed
- Financial information for Galmed
Read the full article on Seeking Alpha
For further details see:
Galmed Pharmaceuticals receives Nasdaq bid price deficiency notice
Galmed Pharmaceuticals Ltd.
NASDAQ: GLMD
GLMD Trading
-2.84% G/L:
$0.6607 Last:
7,364 Volume:
$0.6589 Open:
GLMD Latest News
January 30, 2026 04:15:00 pm
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
December 08, 2025 08:30:00 am
Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting
GLMD Stock Data
$3,725,877
5,281,979
N/A
25
N/A
Biotechnology & Life Sciences
Healthcare
IL
Ramat Gan
